FDA compounder NDC directory
Browse every current FDA compounder source row, including records that do not contain a usable NDC.
Compounder NDC directory#
Every current compounder source row is browsable, including records whose FDA source did not provide a usable product, package, or lookup NDC. Browse the unified current auxiliary catalog. · Browse the complete captured source and snapshot history.
| Establishment | FEI | Product NDC | Package NDC | Brand | Nonproprietary name | Active ingredients | Period | Normalization | Source date |
|---|---|---|---|---|---|---|---|---|---|
| QuVa Pharma, Inc. | 079937015 | 70092-103 | 70092-103-36 | Fentanyl Citrate; Bupivacaine Hydrochloride Anhydrous | 200 ug/100 mL; 100 mg/100 mL | 2025-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 079937015 | 70092-103 | 70092-103-36 | Fentanyl Citrate; Bupivacaine Hydrochloride Anhydrous | 200 ug/100 mL; 100 mg/100 mL | 2025-1 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 70092-103 | 70092-103-36 | Fent 2 mcg/ml-Bup 0.1% PF 100ml NS IVB | Fent 2 mcg/ml-Bup 0.1% PF 100ml NS IVB | 200 ug/100 mL; 100 mg/100 mL | 2025-1 | valid | 2025-09-25 | |
| QuVa Pharma, Inc. | 079937015 | 70092-103 | 70092-103-36 | Fentanyl Citrate; Bupivacaine Hydrochloride Anhydrous | 200 ug/100 mL; 100 mg/100 mL | 2024-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 70092-103 | 70092-103-36 | Fent 2 mcg/ml-Bup 0.1% PF 100ml NS IVB | Fent 2 mcg/ml-Bup 0.1% PF 100ml NS IVB | 200 ug/100 mL; 100 mg/100 mL | 2024-2 | valid | 2025-09-25 | |
| QuVa Pharma | 079937015 | 70092-103 | 70092-103-36 | Fentanyl Citrate; Bupivacaine Hydrochloride Anhydrous | 200 ug/100 mL; 100 mg/100 mL | 2024-1 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 70092-103 | 70092-103-36 | Fent 2 mcg/ml-Bup 0.1% PF 100ml NS IVB | Fent 2 mcg/ml-Bup 0.1% PF 100ml NS IVB | 200 ug/100 mL; 100 mg/100 mL | 2024-1 | valid | 2025-09-25 | |
| QuVa Pharma | 079937015 | 70092-103 | 70092-103-36 | Fentanyl Citrate; Bupivacaine Hydrochloride Anhydrous | 200 ug/100 mL; 100 mg/100 mL | 2023-2 | valid | 2026-08-12 | |
| QuVa Pharma, Inc. | 70092-103 | 70092-103-36 | Fent 2 mcg/ml-Bup 0.1% PF 100ml NS IVB | Fent 2 mcg/ml-Bup 0.1% PF 100ml NS IVB | 200 ug/100 mL; 100 mg/100 mL | 2023-2 | valid | 2025-09-25 | |
| QuVa Pharma | 079937015 | 70092-103 | 70092-103-36 | Fentanyl Citrate; Bupivacaine Hydrochloride Anhydrous | 200 ug/100 mL; 100 mg/100 mL | 2023-1 | valid | 2026-08-12 | |
| QuVa Pharma | 079937015 | 70092-103 | 70092-103-36 | Fentanyl Citrate; Bupivacaine Hydrochloride Anhydrous | 200 ug/100 mL; 100 mg/100 mL | 2022-2 | valid | 2026-08-12 | |
| QuVa Pharma | 079937015 | 70092-103 | 70092-103-36 | Fentanyl Citrate; Bupivacaine Hydrochloride Anhydrous | 200 ug/100 mL; 100 mg/100 mL | 2022-1 | valid | 2026-08-12 |